Fidelity Investments’s ImmuCell ICCC Stock Holding History

Fidelity Investments’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61K	Buy	+160	New	+$1.41K	﹤0.01%	5189
2023 Q2	–	Sell	-1	Closed	-$5	–	5488
2023 Q1	$5	Buy	+1	New	+$6	﹤0.01%	5215

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fidelity Investments's ICCC Position: Q2 2026 in Review

Fidelity Investments opened a new position in ImmuCell (ICCC) in Q2 2026: 160 shares worth $1.61K. The stake represents ﹤0.01% of the portfolio and ranks #5189 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in ICCC as recently as Q1 2023.

Fidelity Investments first reported a position in ICCC in Q1 2023 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Fidelity Investments held 160 shares of ImmuCell worth $1.61K as of Q2 2026.
ImmuCell was a new Fidelity Investments position in Q2 2026.
ImmuCell made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5189 holding.
Fidelity Investments first reported a position in ImmuCell in Q1 2023 and has held it in 2 quarters since.
31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.